North America Genetic Testing Market – Industry Analysis And Market Forecast (2016 - 2021) - Product Image

North America Genetic Testing Market – Industry Analysis And Market Forecast (2016 - 2021)

  • ID: 2964577
  • Report
  • Region: America, North America, United States
  • 109 pages
  • Mordor Intelligence
1 of 4
North America Is The Largest Genetic Testing Market With An Estimated Value of US $8.6 Billion In 2014

FEATURED COMPANIES

  • 23Andme, Inc
  • Abbott Molecular
  • Ariosa Diagnostics, Inc
  • Biomerieux S.A
  • Celera Corporation
  • Cepheid
  • MORE
Genetic testing offers the prospects for fastest growth among all other segments within the molecular diagnostics market. Primary growth drivers for genetic testing include high incidence of genetic diseases, aging population and greater awareness.

Personalized medicine is one area that is likely to benefit greatly from technological developments in genetic testing, which is of assistance not only in better diagnosis of genetic diseases but also in deciding on the most ideal medical regimen based on an individual’s DNA structure for ensuring that the drug responds in a superior manner.

In the realm of personalized medicine Direct-to-consumer (DTC) genetic testing has emerged as a major trend in the market and is expected to make a positive impact on the overall growth of the genetic testing market. The genetic testing market in North America is the largest in the world and is estimated at US$8.6 billion in 2014, and is further anticipated to post a strong CAGR of 18% in 2014-2020. In North America, the United States is set to have the highest demand for genetic testing and this demand is estimated to outpace the cumulative North American CAGR in the time frame 2014 to 2020. Newborn screening leads the region’s genetic testing market.

The research report titled “North American Genetic Testing Market- Industry analysis and Market forecasts” provides an in-depth analysis of the geographical and market based factors that affect the growth of the genetic testing market. The report captures the strategic assessment of Indicators, market impact analysis, regional variation, current/ future market trends and profiles of major/niche global market participants.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 23Andme, Inc
  • Abbott Molecular
  • Ariosa Diagnostics, Inc
  • Biomerieux S.A
  • Celera Corporation
  • Cepheid
  • MORE
1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY

2 NORTH AMERICA GENETIC TESTING – MARKET FORCES
2.1 MARKET DRIVERS
2.1.1 Increase in the Genetic Tests’ Pipeline
2.1.2 Early Confirmation of Genetic Disorders
2.1.3 Minimal Procedure Risk
2.1.4 Guide Strategies for Maintaining Health
2.1.5 Guide Treatment Choices for a variety of Disease Conditions
2.2 MARKET RESTRAINTS
2.2.1 False-Positive and False-Negative Results
2.2.2 Potentially Adverse Personal or Societal Consequences
2.2.3 Non-inclusion of Reimbursement Policy
2.3 OPPORTUNITIES
2.3.1 Genetic Counseling

3 NORTH AMERICA GENETIC TESTING MARKET, BY TYPES
3.1 OVERVIEW
3.1.1 North America Genetic Testing Market, By Types, 2014-2020
3.2 CARRIER TESTING
3.3 DIAGNOSTIC TESTING
3.4 NEWBORN SCREENING
3.5 PREDICTIVE AND PRESYMPTOMATIC TESTING
3.6 PRENATAL TESTING

4 NORTH AMERICA GENETIC TESTING MARKET, BY GEOGRAPHY
4.1 OVERVIEW
4.1.1 North American Genetic Testing Market, by Geography, 2014-2020
4.2 NORTH AMERICA
4.2.1 United States
4.2.2 Canada
4.2.3 Mexico

5. COMPETITIVE LANDSCAPE

6. COMPANY PROFILES
6.1 23ANDME, INC
6.1.1 Overview
6.1.2 Major Products and Services
6.1.3 Genetic Testing Pipeline Products
6.1.4 Financials
6.1.5 Developments
6.2 ABBOTT MOLECULAR
6.2.1 Overview
6.2.2 Major Products and Services
6.2.3 Genetic Testing Pipeline Products
6.2.4 Financials
6.2.5 Developments
6.3 ARIOSA DIAGNOSTICS, Inc
6.3.1 Overview
6.3.2 Major Products and Services
6.3.3 Genetic Testing Pipeline Products
6.4 BIOHELIX CORPORATION (Wholly Owned Subsidiary of Quidel)
6.4.1 Overview
6.4.2 Major Products and Services
6.4.3 Genetic Testing Pipeline Products
6.4.4 Financials
6.4.5 Developments
6.5 BIOMERIEUX S.A
6.5.1 Overview
6.5.2 Major Products and Services
6.5.3 Genetic Testing Pipeline Products
6.5.4 Financials
6.5.5 Developments
6.6 CELERA CORPORATION
6.6.1 Overview
6.6.2 Major Products and Services
6.6.3 Genetic Testing Pipeline Products
6.6.4 Financials
6.6.5 Developments
6.8 CEPHEID
6.8.1 Overview
6.8.2 Major Products and Services
6.8.3 Financials
6.8.4 Developments
6.9 GENENTECH, INC
6.9.1 Overview
6.9.2 Genetic Testing Pipeline Products
6.9.3 Financials
6.9.4 Developments

7. APPENDIX
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- 23Andme, Inc
- Abbott Molecular
- Ariosa Diagnostics, Inc
- Biohelix Corporation (Wholly Owned Subsidiary Of Quidel)
- Biomerieux S.A
- Celera Corporation
- Cepheid
- Genentech, Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll